Cargando…
Discovering new peripheral plasma biomarkers to identify cognitive decline in type 2 diabetes
Type 2 diabetes mellitus (T2DM) is an independent risk factor of Alzheimer’s disease (AD), and thus identifying who among the increasing T2DM populations may develop into AD is important for early intervention. By using TMT-labeling coupled high-throughput mass spectrometry, we conducted a comprehen...
Autores principales: | Yu, Haitao, Gao, Yang, He, Ting, Li, Mengzhu, Zhang, Yao, Zheng, Jie, Jiang, Bijun, Chen, Chongyang, Ke, Dan, Liu, Yanchao, Wang, Jian-Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729784/ https://www.ncbi.nlm.nih.gov/pubmed/36506101 http://dx.doi.org/10.3389/fcell.2022.818141 |
Ejemplares similares
-
Periphery Biomarkers for Objective Diagnosis of Cognitive Decline in Type 2 Diabetes Patients
por: Liu, Yanchao, et al.
Publicado: (2021) -
Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patients
por: Yu, Haitao, et al.
Publicado: (2021) -
High-Throughput Metabolomics for Discovering Potential Biomarkers and Identifying Metabolic Mechanisms in Aging and Alzheimer’s Disease
por: Xie, Kun, et al.
Publicado: (2021) -
Ubiquitination Regulators Discovered by Virtual Screening for the Treatment of Cancer
por: Song, Ying-Qi, et al.
Publicado: (2021) -
Metabolite Profiling of Pig Seminal Plasma Identifies Potential Biomarkers for Sperm Resilience to Liquid Preservation
por: Mateo-Otero, Yentel, et al.
Publicado: (2021)